# Adolescent Mite Allergy Safety Evaluation

> **NCT04541004** · PHASE3 · COMPLETED · sponsor: **ALK-Abelló A/S** · enrollment: 253 (actual)

## Conditions studied

- Allergic Rhinitis
- Allergic Rhinoconjunctivitis

## Interventions

- **BIOLOGICAL:** HDM SLIT-tablet

## Key facts

- **NCT ID:** NCT04541004
- **Lead sponsor:** ALK-Abelló A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-23
- **Primary completion:** 2021-04-24
- **Final completion:** 2021-04-24
- **Target enrollment:** 253 (ACTUAL)
- **Last updated:** 2023-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04541004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04541004, "Adolescent Mite Allergy Safety Evaluation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04541004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*